Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial.
about
Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough StrategyA prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.The effect of thiamine and thiamine pyrophosphate on oxidative liver damage induced in rats with cisplatin.Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC).Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.Radiofrequency heat-enhanced direct intratumoral chemotherapy for prostate cancer.
P2860
Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Toxicity in patients receiving ...... report of the SPCG-13 trial.
@en
type
label
Toxicity in patients receiving ...... report of the SPCG-13 trial.
@en
prefLabel
Toxicity in patients receiving ...... report of the SPCG-13 trial.
@en
P2093
P2860
P356
P1476
Toxicity in patients receiving ...... report of the SPCG-13 trial.
@en
P2093
C Thellenberg-Karlsson
M Hjälm-Eriksson
M Taalikka
P-L Kellokumpu-Lehtinen
T Marttila
P2860
P2888
P304
P356
10.1038/PCAN.2012.13
P577
2012-09-01T00:00:00Z
P6179
1038890402